Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NPD's 30-Y Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

NPD Guru Trades in Q4 2015

Jim Simons 792,400 sh (+3.74%)
» More
Q1 2016

NPD Guru Trades in Q1 2016

Jim Simons 822,100 sh (+3.75%)
» More
Q2 2016

NPD Guru Trades in Q2 2016

Jim Simons 173,500 sh (-78.90%)
» More
Q3 2016

NPD Guru Trades in Q3 2016

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with NPD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Retail - Defensive » Pharmaceutical Retailers  
Compare:NZSE:GXH, BSP:BPHA3, HKSE:03332, XKLS:7668, TSE:8095, WAR:NEU, MIC:APTK, TSE:4350, TSE:3194, HKSE:01110, HKSE:06108, TSE:4926, XKLS:5245, SZSE:002758, MEX:BEVIDES B, TSE:3417, TSE:3544, XKRX:101390, HKSE:01345, HKSE:02211 » details
Traded in other countries:4CSA.Germany,
Headquarter Location:China
China Nepstar Chain Drugstore Ltd are engaged in the business of operating retail drugstores in the People's Republic of China. It provide pharmacy services and other merchandise, including over-the-counter drugs, and nutritional supplements.

China Nepstar Chain Drugstore Ltd was incorporated in the Cayman Islands in August 2004. The Company operates retail drugstore business. The Company provides professional and convenient pharmacy services and other merchandise, including over-the-counter drugs, nutritional supplements, herbal products, personal care products, family care products, as well as convenience products including consumable, seasonal and promotional items. It also offers private label products. The Company offers 523 nutritional supplements, including a variety of healthcare supplements, vitamins, minerals and dietary products. Its other products include personal care products such as skin care, hair care and beauty products, family care products such as portable medical devices for family use, birth control and early pregnancy test products, and convenience products, including soft drinks, packaged snacks, cleaning agents and stationery. The other products also include seasonal and promotional items tailored to local consumer demand for convenience and quality. The Company also provides ancillary services such as providing free blood pressure measurements in its stores. The Company competes with other retail drugstore chains or independent drugstores. As a distributor and retailer of pharmaceutical products, the Company is subject to regulation and oversight by different levels of the food and drug administration in China, in particular, the State Food and Drug Administration, or the SFDA.



Buy Back

5-Year Yield-on-Cost % 11.14
NPD's 5-Year Yield-on-Cost % is ranked higher than
94% of the 516 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.05 vs. NPD: 11.14 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
NPD' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0
Current: 11.14

Valuation & Return


More Statistics

Revenue (TTM) (Mil) $518.12
EPS (TTM) $ 0.08
Short Percentage of Float0.07%
52-Week Range $2.00 - 2.59
Shares Outstanding (Mil)98.70 (ADR)

Piotroski F-Score Details

Piotroski F-Score: ----
Positive ROAN
Positive CFROAN
Higher ROA yoyN
Lower Leverage yoyN
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat